Approval · Notice of Compliance 5364 · 1994
KETOPROFEN-E: Notice of Compliance 5364
Issued March 28, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5364
- Date
- March 28, 1994
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New dosage form
- Therapeutic class
- Anti-inflammatory / analgesic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KETOPROFEN-E | 02084171 | Cancelled Post Market |
| KETOPROFEN-E | 02084198 | Cancelled Post Market |
Medicinal ingredients
- KETOPROFEN 50 MG per TAB
- KETOPROFEN 100 MG per TAB